Chapter/Section Purchase

1 Study Coverage
1.1 Acute Migraine Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Acute Migraine Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Triptans
1.2.3 NSAIDs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Acute Migraine Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Acute Migraine Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Acute Migraine Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Acute Migraine Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Acute Migraine Drugs Sales by Region
2.4.1 Global Acute Migraine Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Acute Migraine Drugs by Region (2023-2028)
2.5 Global Acute Migraine Drugs Revenue by Region
2.5.1 Global Acute Migraine Drugs Revenue by Region (2017-2022)
2.5.2 Global Acute Migraine Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Acute Migraine Drugs Sales by Manufacturers
3.1.1 Global Top Acute Migraine Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Acute Migraine Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Acute Migraine Drugs in 2021
3.2 Global Acute Migraine Drugs Revenue by Manufacturers
3.2.1 Global Acute Migraine Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Acute Migraine Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Acute Migraine Drugs Revenue in 2021
3.3 Global Acute Migraine Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Acute Migraine Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Acute Migraine Drugs Sales by Type
4.1.1 Global Acute Migraine Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Acute Migraine Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Acute Migraine Drugs Sales Market Share by Type (2017-2028)
4.2 Global Acute Migraine Drugs Revenue by Type
4.2.1 Global Acute Migraine Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Acute Migraine Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Acute Migraine Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Acute Migraine Drugs Price by Type
4.3.1 Global Acute Migraine Drugs Price by Type (2017-2022)
4.3.2 Global Acute Migraine Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Acute Migraine Drugs Sales by Application
5.1.1 Global Acute Migraine Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Acute Migraine Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Acute Migraine Drugs Sales Market Share by Application (2017-2028)
5.2 Global Acute Migraine Drugs Revenue by Application
5.2.1 Global Acute Migraine Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Acute Migraine Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Acute Migraine Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Acute Migraine Drugs Price by Application
5.3.1 Global Acute Migraine Drugs Price by Application (2017-2022)
5.3.2 Global Acute Migraine Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Acute Migraine Drugs Market Size by Type
6.1.1 North America Acute Migraine Drugs Sales by Type (2017-2028)
6.1.2 North America Acute Migraine Drugs Revenue by Type (2017-2028)
6.2 North America Acute Migraine Drugs Market Size by Application
6.2.1 North America Acute Migraine Drugs Sales by Application (2017-2028)
6.2.2 North America Acute Migraine Drugs Revenue by Application (2017-2028)
6.3 North America Acute Migraine Drugs Market Size by Country
6.3.1 North America Acute Migraine Drugs Sales by Country (2017-2028)
6.3.2 North America Acute Migraine Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Acute Migraine Drugs Market Size by Type
7.1.1 Europe Acute Migraine Drugs Sales by Type (2017-2028)
7.1.2 Europe Acute Migraine Drugs Revenue by Type (2017-2028)
7.2 Europe Acute Migraine Drugs Market Size by Application
7.2.1 Europe Acute Migraine Drugs Sales by Application (2017-2028)
7.2.2 Europe Acute Migraine Drugs Revenue by Application (2017-2028)
7.3 Europe Acute Migraine Drugs Market Size by Country
7.3.1 Europe Acute Migraine Drugs Sales by Country (2017-2028)
7.3.2 Europe Acute Migraine Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Acute Migraine Drugs Market Size by Type
8.1.1 Asia Pacific Acute Migraine Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Acute Migraine Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Acute Migraine Drugs Market Size by Application
8.2.1 Asia Pacific Acute Migraine Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Acute Migraine Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Acute Migraine Drugs Market Size by Region
8.3.1 Asia Pacific Acute Migraine Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Acute Migraine Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Acute Migraine Drugs Market Size by Type
9.1.1 Latin America Acute Migraine Drugs Sales by Type (2017-2028)
9.1.2 Latin America Acute Migraine Drugs Revenue by Type (2017-2028)
9.2 Latin America Acute Migraine Drugs Market Size by Application
9.2.1 Latin America Acute Migraine Drugs Sales by Application (2017-2028)
9.2.2 Latin America Acute Migraine Drugs Revenue by Application (2017-2028)
9.3 Latin America Acute Migraine Drugs Market Size by Country
9.3.1 Latin America Acute Migraine Drugs Sales by Country (2017-2028)
9.3.2 Latin America Acute Migraine Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Acute Migraine Drugs Market Size by Type
10.1.1 Middle East and Africa Acute Migraine Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Acute Migraine Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Acute Migraine Drugs Market Size by Application
10.2.1 Middle East and Africa Acute Migraine Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Acute Migraine Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Acute Migraine Drugs Market Size by Country
10.3.1 Middle East and Africa Acute Migraine Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Acute Migraine Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GSK Acute Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Overview
11.2.3 Teva Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Teva Acute Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pfizer Acute Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Overview
11.4.3 Novartis Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novartis Acute Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 Sun Pharma
11.5.1 Sun Pharma Corporation Information
11.5.2 Sun Pharma Overview
11.5.3 Sun Pharma Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sun Pharma Acute Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sun Pharma Recent Developments
11.6 Grunenthal
11.6.1 Grunenthal Corporation Information
11.6.2 Grunenthal Overview
11.6.3 Grunenthal Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Grunenthal Acute Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Grunenthal Recent Developments
11.7 Endo Pharmaceuticals
11.7.1 Endo Pharmaceuticals Corporation Information
11.7.2 Endo Pharmaceuticals Overview
11.7.3 Endo Pharmaceuticals Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Endo Pharmaceuticals Acute Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Endo Pharmaceuticals Recent Developments
11.8 Merck
11.8.1 Merck Corporation Information
11.8.2 Merck Overview
11.8.3 Merck Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merck Acute Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merck Recent Developments
11.9 J & J
11.9.1 J & J Corporation Information
11.9.2 J & J Overview
11.9.3 J & J Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 J & J Acute Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 J & J Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Acute Migraine Drugs Industry Chain Analysis
12.2 Acute Migraine Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Acute Migraine Drugs Production Mode & Process
12.4 Acute Migraine Drugs Sales and Marketing
12.4.1 Acute Migraine Drugs Sales Channels
12.4.2 Acute Migraine Drugs Distributors
12.5 Acute Migraine Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Acute Migraine Drugs Industry Trends
13.2 Acute Migraine Drugs Market Drivers
13.3 Acute Migraine Drugs Market Challenges
13.4 Acute Migraine Drugs Market Restraints
14 Key Findings in The Global Acute Migraine Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer